When Early Stage VC Isn’t

One of the biggest barriers to innovation is often the lack of early stage funds available. I recently had a bizarre conversation with a manager at an n early stage technology fund who told me that “we don’t invest in anything more than 12 months away from profitability.” Now I know that early stage investment is risk and scary for a lot …

Advertisements

The Market for Nanotechnology in Drug Delivery in 2010. And The Winners Are…

Cientifica Ltd published Nanotechnology in Drug Delivery 2011  on 2 November 2011. Here’s a few of the key findings.   MARKET ANALYSIS BY KEY TECHNOLOGY   Of All Key Technologies Studied… An analysis of the Total Addressable Market (TAM) in 2010, for nanotechnology in drug delivery (NDD), all key technologies studied shows the following values in 2010 (by descending order): Drug Nanocrystals (596 …

Envisioning The Future of Technology

  Many have tried, but Michell Zappa‘s visualisation of the next 25 years is one of the best and clearest I’ve seen. Now if only there was a way to adjust the due dates and play with the cumulative societal impact I could lose myself in this for weeks!

Nanotechnology in Drug Delivery – Clarifying the Market Opportunities

Some forecasts have predicted the nanotechnology market to reach close to a trillion dollars by 2015, presenting investors with unique opportunities. However, the market for applications of nanotechnology is complex, multidisciplinary and highly segmented. It is therefore essential to gain an understanding of which market sectors nanotechnology is likely to impact most profoundly in the near term. That’s what we …

What Use Is Nanotechnology?

Technology Review, besides being a great magazine edited by Jason Pontin, who I have known since the heyday of Red Herring, also puts on some great conferences. So I was excited and honoured to be invited to EmTech Spain, a two day conference in Malaga focussing on emerging technologies. Along with my World Economic Forum colleague Javier García Martínez of …

Russian Nanotechnology Needs People Not Money

The Moscow Times ran a front page nanotech article looking at Russia’s efforts to commercialise nanotechnologies. At Cientifica we have been involved in setting up and running a huge number of nanotech programs, but the key limiting factor in almost every case is the people – or lack thereof. Russia seems to be hitting the same problem, and while massive investment …

Innovation Starvation or Risk Avoidance?

While working on our report on Using Emerging Technologies to Address Global Risks, one of my favourite SciFi authors, Neal Stephenson, popped up with an essay on Innovation Starvation. It echoes Tyler Cowen‘s arguments that all the easy big stuff has been done,  and that all we have left to look forward to are incremental improvements rather than world changing …

What Is Technology For?

(Foreword to Using Emerging Technologies to Address Global Risks , October 2011) This is a question that often comes up in our dealings with global policy makers who spend huge sums on scientific research while simultaneously being fearful of its consequences. Many believe that it is somehow important for the economy in an undefined and non-quantifiable manner, or that it is some …

Why is Nanotechnology A Dirty Word in the UK?

We have mentioned the UK’s slightly odd approach to merging technologies in the past (usually involving talking rather than doing) and an editorial in this weeks Nature looks at the relationship between regenerative medicine and nanotechnology. While just about everybody involved in regenerative medicine will understand the value of scaffolds – stem cells don’t just grow into a new windpipe …